Waddell & Reed Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $65.3M | Sell |
|
|||||
|
2019
Q1 | $224M | Sell |
|
|||||
|
2018
Q4 | $244M | Sell |
|
|||||
|
2018
Q3 | $314M | Sell |
|
|||||
|
2018
Q2 | $314M | Buy |
|
|||||
|
2018
Q1 | $258M | Buy |
|
|||||
|
2017
Q4 | $218M | Buy |
|
|||||
|
2017
Q3 | $222M | Buy |
|
|||||
|
2017
Q2 | $104M | Buy |
|
|||||
|
2017
Q1 | $99.3M | Sell |
|
|||||
|
2016
Q4 | $95.6M | Sell |
|
|||||
|
2016
Q3 | $109M | Buy |
|
|||||
|
2016
Q2 | $86.2M | Buy |
|
|||||
|
2016
Q1 | $85.4M | Sell |
|
|||||
|
2015
Q4 | $114M | Buy |
|
|||||
|
2015
Q3 | $115M | Sell |
|
|||||
|
2015
Q2 | $200M | Buy |
|
|||||
|
2015
Q1 | $180M | Sell |
|
|||||
|
2014
Q4 | $137M | Sell |
|
|||||
|
2014
Q3 | $118M | Buy |
|
|||||
|
2014
Q2 | $99.3M | Buy |
|
|||||
|
2014
Q1 | $68.6M | Buy |
|
|||||
|
2013
Q4 | $7.03M | Buy |
|